JP2004524014A5 - - Google Patents

Download PDF

Info

Publication number
JP2004524014A5
JP2004524014A5 JP2002552000A JP2002552000A JP2004524014A5 JP 2004524014 A5 JP2004524014 A5 JP 2004524014A5 JP 2002552000 A JP2002552000 A JP 2002552000A JP 2002552000 A JP2002552000 A JP 2002552000A JP 2004524014 A5 JP2004524014 A5 JP 2004524014A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002552000A
Other languages
Japanese (ja)
Other versions
JP2004524014A (ja
JP4080876B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2001/001853 external-priority patent/WO2002050107A2/en
Publication of JP2004524014A publication Critical patent/JP2004524014A/ja
Publication of JP2004524014A5 publication Critical patent/JP2004524014A5/ja
Application granted granted Critical
Publication of JP4080876B2 publication Critical patent/JP4080876B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002552000A 2000-12-21 2001-12-21 ストレプトコッカス・ピオゲネス抗原及び対応するdnaフラグメント Expired - Fee Related JP4080876B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25694000P 2000-12-21 2000-12-21
PCT/CA2001/001853 WO2002050107A2 (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Publications (3)

Publication Number Publication Date
JP2004524014A JP2004524014A (ja) 2004-08-12
JP2004524014A5 true JP2004524014A5 (enExample) 2005-12-22
JP4080876B2 JP4080876B2 (ja) 2008-04-23

Family

ID=22974225

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002552000A Expired - Fee Related JP4080876B2 (ja) 2000-12-21 2001-12-21 ストレプトコッカス・ピオゲネス抗原及び対応するdnaフラグメント

Country Status (12)

Country Link
US (5) US7595057B2 (enExample)
EP (1) EP1343895B1 (enExample)
JP (1) JP4080876B2 (enExample)
AT (1) ATE398677T1 (enExample)
AU (2) AU1686302A (enExample)
BE (1) BE2021C506I2 (enExample)
BR (1) BR0116704A (enExample)
CA (2) CA2789252C (enExample)
DE (1) DE60134494D1 (enExample)
ES (1) ES2307564T3 (enExample)
FR (1) FR21C1005I2 (enExample)
WO (1) WO2002050107A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
WO2005017093A2 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
WO2024206953A2 (en) * 2023-03-29 2024-10-03 Taktos Therapeutics Inc. Ides variant proteins and methods of using the same

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
ES2278436T3 (es) * 1998-02-20 2007-08-01 Id Biomedical Corporation Antigenos de estreptococos del grupo b.
GB9807890D0 (en) 1998-04-09 1998-06-10 Actinova Ltd Peptides
JP2002531055A (ja) 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド 肺炎連鎖球菌のタンパク質及び核酸分子
JP2002531054A (ja) 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド B群連鎖球菌由来の核酸およびタンパク質
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9828880D0 (en) 1998-12-31 1999-02-17 Actinova Ltd Protein
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
AU7227001A (en) * 2000-07-06 2002-01-21 Shire Biochem Inc Streptococcus pyogenes antigens
AU2002210301A1 (en) * 2000-10-13 2002-04-22 Shire Biochem Inc. Bvh-a2 and bvh-a3 antigens of group b streptococcus
WO2002034771A2 (en) * 2000-10-27 2002-05-02 Chiron Srl Nucleic acids and proteins from streptococcus groups a & b
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
ES2338637T3 (es) * 2001-02-21 2010-05-11 Id Biomedical Corporation Polipeptidos de streptococcus pyogenes y fragmentos de adn correspondiente.
US20040236072A1 (en) * 2001-04-13 2004-11-25 Olmsted Stephen Bruce Surface proteins of streptococcus pyogenes
CA2453062C (en) * 2001-07-06 2013-04-02 Shire Biochem Inc. Group b streptococcus bvh-a5 antigens and corresponding dna fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
AU2002351623A1 (en) * 2001-12-20 2003-07-09 Shire Biochem Inc. Streptococcus antigens
AU2003246495A1 (en) * 2002-07-15 2004-02-02 Id Biomedical Corporation Polypeptide of streptococcus pyogenes
WO2005017093A2 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
AU2005294275B2 (en) * 2004-10-08 2012-09-13 Glaxosmithkline Biologicals S.A. Immunogenic and therapeutic compositions for Streptococcus pyogenes
PL1901773T3 (pl) * 2005-06-09 2012-09-28 Hansa Medical Ab Zastosowanie proteinazy IDES (Z S. Pyogenes) do leczenia chorób autoimmunologicznych oraz odrzutów przeszczepu
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
DK2190984T3 (da) * 2007-09-14 2013-12-02 Genovis Ab Fremgangsmåder og kits til oprensning og påvisning af glycosyleret IgG
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method

Similar Documents

Publication Publication Date Title
BE2022C531I2 (enExample)
BE2022C547I2 (enExample)
BE2017C059I2 (enExample)
BE2017C057I2 (enExample)
BE2017C051I2 (enExample)
BE2017C032I2 (enExample)
BE2016C051I2 (enExample)
BE2015C077I2 (enExample)
BE2014C052I2 (enExample)
BE2014C036I2 (enExample)
BE2014C026I2 (enExample)
IN2004MU00015A (enExample)
JP2001285721A5 (enExample)
BE2014C006I2 (enExample)
BRPI0209186B1 (enExample)
JP2002069889A5 (enExample)
BE2017C050I2 (enExample)
BRPI0204884A2 (enExample)
CH1379220H1 (enExample)
BE2014C008I2 (enExample)
BE2016C021I2 (enExample)
JP2001254696A5 (enExample)
JP2001326289A5 (enExample)
BRPI0101486B8 (enExample)
BE2012C051I2 (enExample)